scholarly article | Q13442814 |
P50 | author | Ogobara K. Doumbo | Q3349810 |
Julian Rayner | Q22278468 | ||
Pietro Cicuta | Q41600942 | ||
Tuan M Tran | Q50285663 | ||
Gareth T. Powell | Q55294206 | ||
Gavin J. Wright | Q55838269 | ||
Theo Sanderson | Q56368622 | ||
Boubacar Traore | Q62672878 | ||
Peter D Crompton | Q91078865 | ||
Cecile Crosnier | Q91288456 | ||
Leyla Y Bustamante | Q125171041 | ||
P2093 | author name string | Yen-Chun Lin | |
Alison Kemp | |||
Michael D Macklin | |||
Nadia Cross | |||
Nicole Muller-Sienerth | |||
Paula Cawkill | |||
P2860 | cites work | Spread of artemisinin resistance in Plasmodium falciparum malaria | Q21032481 |
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum | Q24297064 | ||
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells | Q24548319 | ||
Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system | Q26700012 | ||
Paths to a malaria vaccine illuminated by parasite genomics | Q26853267 | ||
Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate | Q27230019 | ||
Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion | Q27230042 | ||
Revealing the sequence and resulting cellular morphology of receptor-ligand interactions during Plasmodium falciparum invasion of erythrocytes | Q27321307 | ||
Biochemical analysis of the Plasmodium falciparum erythrocyte-binding antigen-175 (EBA175)-glycophorin-A interaction: implications for vaccine design | Q27973510 | ||
A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle | Q27974188 | ||
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015 | Q28267425 | ||
A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720 | Q28744696 | ||
Deletion of the Plasmodium falciparum merozoite surface protein 7 gene impairs parasite invasion of erythrocytes | Q30042482 | ||
Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum | Q30044443 | ||
Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen | Q30049113 | ||
Essential Role of the PfRh5/PfRipr/CyRPA Complex during Plasmodium falciparum Invasion of Erythrocytes | Q30049125 | ||
Genomic epidemiology of artemisinin resistant malaria | Q31075546 | ||
Antibodies to rhoptry-associated membrane antigen predict resistance to Plasmodium falciparum | Q33221359 | ||
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya | Q33415066 | ||
An adaptable two-color flow cytometric assay to quantitate the invasion of erythrocytes by Plasmodium falciparum parasites | Q33703948 | ||
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray | Q33859633 | ||
Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria | Q33925720 | ||
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial | Q34043843 | ||
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody | Q34241973 | ||
An expanding ebl family of Plasmodium falciparum | Q34264741 | ||
An automated live imaging platform for studying merozoite egress-invasion in malaria cultures | Q34615281 | ||
A library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins | Q34991300 | ||
New antigens for a multicomponent blood-stage malaria vaccine | Q35216634 | ||
Basigin is a druggable target for host-oriented antimalarial interventions | Q35894355 | ||
Antimalarial drug synergism and antagonism: mechanistic and clinical significance. | Q36294193 | ||
A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants | Q36511421 | ||
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine | Q36603519 | ||
Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria | Q37582331 | ||
Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum | Q37598726 | ||
A genome-wide map of diversity in Plasmodium falciparum | Q44045368 | ||
Kinetic constraints on the development of a malaria vaccine | Q47887346 | ||
P433 | issue | 45 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | malaria | Q12156 |
malaria vaccine | Q6741353 | ||
P304 | page(s) | 12045-12050 | |
P577 | publication date | 2017-10-23 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Synergistic malaria vaccine combinations identified by systematic antigen screening | |
P478 | volume | 114 |
Q58118436 | A library of recombinant Babesia microti cell surface and secreted proteins for diagnostics discovery and reverse vaccinology |
Q57295570 | A plug-and-play approach for malaria vaccination |
Q93064802 | Adaptive NK cells in people exposed to Plasmodium falciparum correlate with protection from malaria |
Q92095524 | Antibodies against a short region of PfRipr inhibit Plasmodium falciparum merozoite invasion and PfRipr interaction with Rh5 and SEMA7A |
Q97548491 | Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations |
Q92058833 | Constituting a glutathione S-transferase-cocktail vaccine against tick infestation |
Q92993772 | Erythrocyte glycophorins as receptors for Plasmodium merozoites |
Q64967277 | Functional Comparison of Blood-Stage Plasmodium falciparum Malaria Vaccine Candidate Antigens. |
Q92781089 | Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies |
Q56383949 | Malaria |
Q56362064 | Malaria Vaccines: Recent Advances and New Horizons |
Q94602401 | Malaria vaccines: facing unknowns |
Q92972427 | Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes |
Q89559300 | Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models |
Search more.